Ceylan A.Çöplü N.Saka G.Gül K.Sönmez C.Esen B.Bozyel O.A.2024-04-242024-04-2420111303-734Xhttps://doi.org/10.5455/pmb.20110306123422https://hdl.handle.net/11468/23913AIM: At the aim of this study was to determine the tetanus seroprevalence among pregnant women and childbearing aged woman living in the Ben-u Sen Health Center region that is in lower socio-economical level. METHOD: In this descriptive study, a team including the staff of health center and several volunteers visited the houses of pregnant women living in the health center coverage region and questionnaires were completed through face to face interviews. The study group included 214 pregnant women. Among them, serum samples of 197 subjects' were studied for anti-toxic antibody for tetanus. For control, serum samples from 200 women living in the same health center region were collected. It was evaluated as partially protective, protective and longterm protection when tetanus antibody level was 0,01-<0,1 IU/ml, 0,1-<1.0 IU/ml and 1,0 IU/ml and over, respectively. RESULTS: The mean age of the women was 26.4, mean marriage and first pregnancy ages were 17.9 and 18.9, respectively, and 40% of the subjects had never been examined or received follow up by a health center. It was revealed that 25.8% of the subjects were not protected and 74.2% had a full protection level of antibody. Within the control group, the same levels of antibodies were detected in 40.0% and 60.0% of the women, respectively. CONCLUSION: The study indicates that the immunity levels against tetanus are not satisfactory and every childbearing aged woman should be included in a vaccination program whenever they receive any examination in a health center.eninfo:eu-repo/semantics/closedAccessMaternal HealthMaternal Neonatal TetanusTetanus SerosurveyTetanus Vaccination İn PregnancyArticle1044814862-s2.0-8005274826210.5455/pmb.20110306123422N/A